Results 161 to 170 of about 22,299 (230)

Methadone Treatment for Heroin Dependence

, 2018
Luiza, Baconi Daniela, Ciobanu, Anne Marie, Vasile, Robert Daniel, Vlasceanu, Ana-Maria, Nedelescu, Mirela, Stan, Miriana   +5 more
openaire   +3 more sources

Post-Heroin Post-Traumatic Stress Disorder Spectrum: Heroin Addiction as a Generator of Trauma Sensitisation in Everyday Life: A Perspective Review. [PDF]

J Clin Med
Maremmani I, Della Rocca F, Carbone MG, Maremmani AGI.   +3 more
europepmc   +1 more source

Proteomic Insights into Heroin Use: Links to Neurodegeneration. [PDF]

Mol Neurobiol
Sürmen MG, Pence S, Sürmen S, Buyuk Y, Kuras S, Elibol B, Pence HH.   +6 more
europepmc   +1 more source

What Is Known about Substance Use in Hawai'i: A Scoping Review. [PDF]

Hawaii J Health Soc Welf
Hong S, Emory-Khenmy C, Ajimura A, Williams G.   +3 more
europepmc   +1 more source

Association between the location of Opioid Agonist Treatment (OAT) providers and heroin-related ambulance attendances. [PDF]

Subst Abuse Treat Prev Policy
Hall N, Rowland B, Ogeil RP, Loos R, Nehme Z, Lubman DI.   +5 more
europepmc   +1 more source

Assessing the Effect of Abstinent Duration on Brain Function in Heroin-Dependent Individuals During Protracted Abstinence: A Resting-State fMRI Study. [PDF]

Addict Biol
Li X, Li W, Chen J, Jin L, Wang Z, Dang L, Wang W, Qin Y, Li Q.   +8 more
europepmc   +1 more source

Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents. [PDF]

Mol Psychiatry
Soler-Cedeño O, Zhang HY, Xiong E, Bi GH, Alton H, Maras M, Liu QR, Bhattacharjee P, Iyer MR, Xi ZX.   +9 more
europepmc   +1 more source

Genetic and Epigenetic Approaches to Opioid Use Disorder. [PDF]

Expert Rev Mol Med
Ranadeva ND, Wijekumar PJ, Fernando CA, Jayamaha AR, Noordeen N, Chackrewarthy S, Fernando N.   +6 more
europepmc   +1 more source

Gas Station Heroin: A Case Report of Tianeptine Use Disorder and a Literature Review. [PDF]

Cureus
Kandra K, Gajagowni R, Fernandez GA, Polechonski N, Blewett BP.   +4 more
europepmc   +1 more source

Assessment of Cognitive Impairment Between Natural and Synthetic Opioid Users.

J Pharm Bioallied Sci
Aluna A, Kumar P, Mahajan NS, Mahajan R, Miglani M.   +4 more
europepmc   +1 more source